Covance Is Now Labcorp Drug Development

We are one global company innovating for millions – together, continuing to bring you more advanced medical breakthroughs.

Learn More

Drug Discovery Support

Contact Us

Cardiovascular telemetry in rodents and large animals

EEG – telemetry, surface electrodes

Investigative and Respiratory discovery models studies

Address liabilities pertaining to both cardiovascular — and non-cardiovascular — targeted drugs, earlier than ever before. “Frontloading” your program is a process where you address cardiovascular or seizure liability safety endpoints prior to the selection of your drug candidate. Although not mandated by the key regulatory guidance for safety pharmacology, an increasing number of companies choose to conduct early non-GLP safety studies in support of decisions on the progression of their compounds. These studies can be incorporated in Lead Optimization toxicology programs or integrated with mechanistic endpoints.

Start your discovery efficacy and early safety respiratory studies right with lead optimization in vivo and in vitro models.

Let's Start the Conversation

Contact Us